Introduction
============

Heme (Fe-protoporphyrin IX) is an essential cofactor for many fundamental biological processes. It is a hydrophobic and cytotoxic macrocycle, which therefore requires specific pathways to be safely delivered to its subcellular destinations. The *c*-type cytochromes (cyts) are most frequently characterized by the covalent attachment of heme to the protein by two thioether bonds formed between the heme vinyl groups and the thiols of two cysteines in a conserved CXXCH motif, with histidine as one of the axial ligands to the heme iron. Binding of *c*-heme comprises several critical steps including the reduction of cysteine residues, ferrous heme-supply, and heme-binding by itself. Factors involved in covalent heme binding have been extensively studied in prokaryotes and eukaryotes, and this maturation process usually occurs through one of three multifactorial systems (I, II, and III), depending on the biological organism and cellular compartment that are known to operate on the positive side (*p* side) of the membrane facing the periplasmic/intermembrane/lumenal space ([@bib20]; [@bib43]; [@bib2]; [@bib11]; [@bib13]; [@bib15]). It has been recently recognized that there are in fact two independent *c*-heme maturation pathways in the chloroplast: system II, also referred to as cyt *c* synthesis (CCS) on the *p* side of membranes ([@bib45]; [@bib19]); and the newly characterized system IV, also referred to as cofactor assembly on complex C subunit B (CCB) on the negative side (*n* side) of photosynthetic membranes facing the chloroplast stroma or cyanobacterial cytoplasm ([@bib22]).

Cyt *bc* complexes that associate *c*-type hemes, *b*-type hemes, and iron--sulfur centers are ubiquitous in energy-transducing membranes, where they transfer electrons from a lipid-soluble carrier to a water-soluble protein carrier, while building up a transmembrane proton gradient. Although quite similar to the *bc*~1~ complex, its homologue found in bacteria and mitochondria, the *b*~6~ *f* complex contains additional cofactors. Six years ago, the discovery of an additional heme bound to the protein backbone of cyt *b*~6~ ([@bib23]; [@bib42]) came as a major surprise. This new *c*-heme showed unusual features. It is covalently attached by a unique thioether bond to the conserved Cys-35 of the *b*~6~ subunit (*Chlamydomonas reinhardtii* numbering), and thus belongs to the *c*-type family. It is a high spin *c*′-heme, with a pentacoordinated central iron. The usual amino acid axial ligands of the heme iron are missing, but a water molecule (or hydroxide ion) acts as a unique axial ligand and bridges the heme iron to a propionate side chain of *b*~H~-heme. Furthermore, *c*~i~-heme is attached on the membrane *n* side in the quinone-binding pocket Q~i~ in very close proximity to *b*~H~-heme, opposite to the location of *f*-heme and *c*~6~-heme that are on the membrane *p* side.

Our previous genetic studies in *C. reinhardti* led to the identification of four nuclear *CCB* loci that control the process of apo- to holo-cyt *b*~6~ conversion that involves binding of *c*~i~-heme ([@bib14]; [@bib21], [@bib22]; [@bib7]). The signature of cyt *b*~6~ impaired in *c*~i~-heme binding was characterized in the *petB-C35V* mutant (the *petB* gene codes for cyt *b*~6~), where the unique covalent cysteine ligand to the heme was substituted by a valine ([@bib7]). It consists of a double band on urea-SDS-polyacrylamide gels or a single band of lower apparent molecular mass than in the wild type (WT) on SDS-polyacrylamide gels that shows no peroxidase activity. The same signature is observed in all *ccb* mutants, which indicates that they do not undergo binding of *c*~i~-heme to cyt *b*~6~. This entirely new biogenesis pathway comprises at least the four CCB factors, which are present in all photosynthetic organisms containing *b*~6~ *f* complexes (available under GenBank/EMBL/DDBJ accession nos. [EF190472](EF190472), [EF190473](EF190473), [EF190474](EF190474), and [EF190475](EF190475)), for which no function had been previously ascribed ([@bib22]). CCB1 is ubiquitous among organisms performing oxygenic photosynthesis, where it is present as a unique orthologue. CCB3, which is the most conserved member of the CCB pathway, belongs to the large YGGT protein family (InterPro accession no. [IPR003425](IPR003425)) found in both plastids and bacteria. CCB2 and CCB4 are encoded by paralogue genes in *C. reinhardtii* with a low similarity level and derived from a unique cyanobacterial ancestor. We recently demonstrated the conserved function of the CCBs in *Arabidopsis* *thaliana* chloroplasts, where they are also involved in *c*~i~-heme binding to cyt *b*~6~ ([@bib26]).

Here, using *C. reinhardtii* as an experimental system for the investigation of the CCB maturation pathway, we extended our previous biochemical work that established the chloroplast membrane localization of CCBs ([@bib22]). We examined the topology and interactions between the CCBs as well as with cyt *b*~6~ and demonstrate that the CCB pathway is organized within the thylakoid membrane in a series of distinct protein complexes that control the covalent binding of *c*~i~-heme to cyt *b*~6~.

Results
=======

CCBs are transmembrane proteins that resist extraction with chaotropic agents
-----------------------------------------------------------------------------

In our previous work, the CCB1--4 proteins were immunodetected as chloroplast membrane proteins after subcellular fractionation in *C. reinhardtii* ([@bib22]). Using fluorescent protein reporters, we also demonstrated that the CCB1--4 proteins are targeted to the chloroplast in *A. thaliana* ([@bib26]).

We further analyzed the transmembrane topologies of these proteins in *C. reinhardtii* by membrane treatment with chaotropic agents and by subjecting oriented thylakoid membranes vesicles to protease treatments followed by urea/SDS-PAGE and immunodetection with anti-CCB peptide antibodies. When membranes were treated with various chaotropic agents or incubated at high ionic strength or alkaline pH, a typical peripheral membrane polypeptide (oxygen evolution enhancer 2 protein of photosystem \[PS\] II \[OEE2\]) was released in the supernatant ([Fig. 1 a](#fig1){ref-type="fig"}). In contrast, cyt *f* was not extracted by these treatments, as expected from its transmembrane domain (TMD). All CCB factors behaved as bona fide transmembrane proteins. Although CCB3 resisted extraction at high ionic strength and alkaline pH, we noted that some CCB3 dissociated from the membrane with the chaotropic agent KSCN, which is intriguing for such a highly hydrophobic protein.

![**Transmembrane topology analysis of CCBs.** Samples were separated by SDS-PAGE and analyzed by ECL immunodetection with antipeptide antibodies against CCB1, CCB2, CCB3, and CCB4; and with antisera against intrinsic cyt *f*, extrinsic OEE2, and OEE3 PSII subunits. (a) Extraction of membrane proteins by dissociating treatments. Membranes were frozen and thawed twice in the indicated solutions: 20 mM tricine-NaOH buffer, pH 8.0 (Tricine), 2 M NaCl in 20 mM tricine-NaOH buffer, pH 8.0 (NaCl), 1.5 M NaI in 20 mM tricine-NaOH buffer, pH 8.0 (NaI), 2 M KSCN in 20 mM tricine-NaOH buffer, pH 8.0 (KSCN), 0.1 M Na~2~CO~3~ (Na~2~CO~3~), and 0.1 M Na~2~CO~3~ + 0.1 M DTT (DTT-Na~2~CO~3~). The supernatant and the pellet were recovered after a 100,000-*g* centrifugation. The pellet was extracted a second time using an identical procedure. The first supernatant (S) and the second pellet (P) were analyzed. (b) Proteolysis of membrane vesicles. Membrane vesicles were incubated for 30 min with increasing trypsin protease concentrations (an endoproteinase cutting after positively charged residues in Lys-C and Arg-C) and sonicated (+) or not sonicated (−). (c) Schematized transmembrane topology predicted by sequence analysis and consistent with chaotrope extraction, protease accessibility, and split ubiquitin data. The numbers of positively charged residues after the positive inside rule are indicated for predicted mature protein when a different total number of positively charged residues is also indicated in parenthesis. Antipeptide localizations are circled.](JCB_200812025_GS_Fig1){#fig1}

The transmembrane topology of the CCBs was assessed by protease treatment of French press--derived membrane vesicles. Membrane vesicles subjected or not subjected to sonication were incubated in the presence of trypsin ([Fig. 1 b](#fig1){ref-type="fig"}). Before sonication, most of the thylakoid vesicles were in a right-side-out orientation, and exogenous proteases have no access to their lumenal side. In contrast, upon sonication, the vesicles burst, and exogenous proteases gain access to both sides of the membranes. Typically, the PSII subunit OEE3, used here as a control for peripheral proteins on the lumenal side of the membranes, is degraded only after sonication, when using trypsin concentrations below 10 μg/ml. In contrast, CCB1, CCB2, and CCB4 proteins are degraded by trypsin treatments below 10 μg/ml even in the absence of sonication. Only CCB3 required higher trypsin concentration (100 μg/ml) for degradation, confirming its deep embedment in the membrane. The lumenal localization of the C terminus of CCB3 was supported by the lack of detection of a CCB3 digestion product corresponding to the mature protein missing the three C-terminal amino acid residues. Therefore, we conclude that the four CCB factors have stromal-exposed segments containing Lys and Arg residues as schematized in the transmembrane topology of the CCBs in [Fig. 1 c](#fig1){ref-type="fig"} (which also shows the localization of the epitopes against which our antibodies were prepared).

Concerted accumulation of CCB2 and CCB4 in *ccb* mutants
--------------------------------------------------------

Each of the CCBs---CCB1 (24 kD), CCB2 (27 kD), CCB3 (13 kD), and CCB4 (28 kD)---is absent in the corresponding *ccb* mutant ([@bib22]). In a first attempt to identify possible interactions between CCB factors, we wondered whether the absence of one CCB factor in the corresponding *ccb* mutant would alter the accumulation pattern of the other CCBs. CCB1 and CCB3 accumulated to the WT level, independently of the presence or absence of the other CCBs ([Fig. 2](#fig2){ref-type="fig"}). The accumulation of CCB2 and CCB4 was similar in WT, *ccb1*, and *ccb3* mutants, and therefore independent of CCB1 and CCB3 accumulation ([Fig. 2](#fig2){ref-type="fig"}). However, CCB4 was barely detectable in the *ccb2* mutant, and, conversely, CCB2 was barely detectable in the *ccb4* mutant ([Fig. 2](#fig2){ref-type="fig"}). Thus, CCB2 and CCB4 show a concerted accumulation that suggests they form a heterodimer. We then looked at whether the presence of cyt *b*~6~, as a substrate for *c*~i~-heme binding, controlled the accumulation of the CCBs. We observed that the four CCBs still accumulated to the WT level in a mutant lacking cyt *b*~6~ (*ΔpetB*) or in the *petB-C35V* mutant that bears a point mutation in the sequence of cyt *b*~6~ that prevents *c*~i~-heme binding ([Fig. 2](#fig2){ref-type="fig"}; [@bib7]).

![**Immunodetection of CCBs in WT and mutant cells.** *ccb* strains: nuclear mutants affecting specifically binding of *c*~i~-heme to cyt *b*~6~. *petB-C35V* strain: site-directed mutant of the chloroplast *petB* gene encoding cyt *b*~6~ with a substitution of Cys35 preventing thioether bonding of *c*~i~-heme to cyt *b*~6~. *ΔpetB* strain: *petB* deletion strain. Whole cell proteins were separated by SDS-PAGE and analyzed by immunoblotting. A subunit of mitochondrial ATP synthase was immunodetected as a loading control (β).](JCB_200812025_GS_Fig2){#fig2}

Direct interaction of CCB2 and CCB4 in yeast split ubiquitin two-hybrid assays
------------------------------------------------------------------------------

We further investigated CCB2--CCB4 interactions using the yeast split ubiquitin system that is appropriate for testing interactions between two transmembrane proteins (as chloroplast membrane proteins \[[@bib32]\] and components of the cyt *c* maturation system I \[[@bib35]\]). Their interaction allows reconstitution of an active ubiquitin from its N and C terminus domains (Nub and Cub), fused, respectively, to each protein. The restored ubiquitin activity cleaves a transcription factor fused to Cub, thereby releasing auxotrophy for some particular nutrients.

Yeast cotransformed with CCB2 and CCB4 were able to grow on a very stringent medium for two reciprocal couples, either CCB2 fused to NubG with CCB4 fused to Cub (CCB2-N/CCB4-C) or CCB4 fused to NubG with CCB2 fused to Cub (CCB4-N/CCB2-C; [Fig. 3 a](#fig3){ref-type="fig"}). The interaction between CCB2 and CCB4 was confirmed by β-galactosidase activity assays ([Fig. 3 b](#fig3){ref-type="fig"}). The strength of the interaction between CCB2 and CCB4 was similar for the two reciprocal sets of constructs. In contrast, CCB2 fused both to NubG and to Cub or CCB4 fused both to NubG and to Cub (respectively, CCB2-N/CCB2-C and CCB4-N/CCB4-C) did not allow better growth than observed in control strains (yeast cotransformed with noninteracting Alg5 fused to NubG or Cub). These results argue for hetero-oligomerization of CCB2 with CCB4 with no homo-interaction between two copies of CCB2 or of CCB4. We could not find any evidence for a hetero-oligomerization between separate domains of CCB2 and CCB4, whether we tested soluble or TMDs of each protein (not depicted). With this technique, we also found no evidence for an interaction between CCB1 and CCB2 or CCB4 (not depicted). Finally, no interactions between any of these three CCBs and cyt *b*~6~ could be detected in split ubiquitin assays (unpublished data). We note, however, that a positive control for the expression of CCB1, using cotransformation of the C terminus of CCB1 fused to Cub and Alg5 fused to NubI, further supported the localization of the C terminus of CCB1 in the cytosol (not depicted). The transmembrane configuration of CCB3 with its N and C termini in the lumen prevented us from studying CCB3 interactions in the split ubiquitin system, which requires an N or C terminus of the protein of interest to be present in the yeast cytoplasm.

![**CCB2 and CCB4 interaction in a yeast split ubiquitin two-hybrid assay.** Constructs CCB2-N or 4-N expressing CCB2 (or 4) mature protein fused to the mutated N-terminal half of ubiquitin NubG were cotransformed in yeast with constructs CCB2- (or 4)-C expressing CCB2 (or 4) protein fused the C-terminal half of ubiquitin Cub; tests of these protein interactions are shown on the left side of the broken line. Constructs expressing yeast protein Alg5, not expected to interact with CCBs, fused to Cub or NubG, were cotransformed, respectively with the CCB2- (or 4)-N or CCB2- (or 4)-C constructs; results of these controls are shown on the right side of the broken line. The interaction between two proteins at the membrane of yeast allows ubiquitin reconstitution and results in the activation of auxotrophic growth markers *ADE2* and *HIS3* and reporter gene *lacZ*. (a) To monitor expression of auxotrophic growth markers *ADE2* and *HIS3*, several cotransformant clones were resuspended in water to an OD~600nm~ of 1, 0.1, and 0.01; plated on SD medium lacking leucine, tryptophan, histidine, and adenine with 10 mM 3-aminotriazole; and allowed to grow for 30 h. (b) Expression of *lacZ* was followed by measuring at OD~417nm~ the accumulation of the product metabolized by β-galactosidase. Liquid SD medium lacking leucine and tryptophan was inoculated with several cotransformant clones, and cultures were allowed to grow for 16 h. After cell lysis, β-galactosidase activity was measured as described in Materials and methods and quantified according to the following formula: Activity = 1,000 × DO~417nm~/V × t × DO~600nm~, were V is the volume of assay and t is the time of incubation. All assays were repeated three times and the resulting error bars are shown.](JCB_200812025_GS_Fig3){#fig3}

CCB complexes analyzed on blue native (BN)-PAGE
-----------------------------------------------

To get a broader picture of the variety of membrane protein complexes that may contain CCBs, we separated oligomeric proteins on BN-PAGE, after a mild digitonin solubilization of thylakoid membranes, using a procedure similar to the one that has been developed for membrane protein complexes from mitochondria ([@bib39]; [@bib29]) and from chloroplasts ([@bib24]). The constitutive subunits of the oligomers were separated in a second dimension on SDS-PAGE, followed by immunoblotting with antibodies raised against each CCB or against some of the major *b*~6~ *f* complex subunits. [Fig. 4](#fig4){ref-type="fig"} compares BN-PAGE assays in the WT and in a series of mutant strains defective for *c*~i~-heme binding to cyt *b*~6~. In agreement with the concerted accumulation and split ubiquitin experiments that demonstrated extensive interactions between CCB2 and CCB4, we observed that these two CCB components comigrate at 70 kD by BN-PAGE ([Fig. 4](#fig4){ref-type="fig"}, circles) in all strains except in the *ccb2* mutant ([Fig. 4](#fig4){ref-type="fig"}) and *ccb4* mutant (not depicted), which lack these two proteins. Therefore, we attribute this 70-kD complex to the CCB2/CCB4 heterodimer. Monomeric forms of CCB2 and CCB4 that probably result from dissociation of the heterodimer were also detected in these experiments, with an apparent molecular mass of ∼45 kD and 50 kD, respectively.

![**CCB complexes after BN-PAGE of digitonin-solubilized membranes.** Same strains are shown as in [Fig. 2](#fig2){ref-type="fig"}. Digitonin-solubilized proteins were separated in the first dimension by BN-PAGE and in the second dimension by SDS-PAGE, and analyzed by ECL immunodetection. The positions of the molecular weight markers are indicated: thyroglobulin, 669 kD; ferritin, 440 kD; aldolase, 158 kD; conalbumin, 75 kD; and ovalbumin, 43 kD. The CCB2/CCB4 heterodimer is circled. CCB2/CCB4/CCB3 comigration is indicated by a solid box. CCB1/*b*~6~ comigration is indicated by dashed boxes. Cyt *b*~6~ was immunodetected after deprobing α-CCB1 immunodetection, and therefore shows residual detection of CCB1 and cross-reactant below CCB1.](JCB_200812025_GS_Fig4){#fig4}

Among the various *c*~i~-heme--binding mutants that we assayed in BN-PAGE, the *petB-C35V* mutant, which is specifically blocked at the last stage of the binding process due to the replacement of the cysteine covalent ligand of the heme by an inactive valine, is the only one that has the same CCB complement as in the WT. A conspicuous feature of the immunodetection pattern in *petB-C35V* is the increased detection of several CCB-containing oligomers that were present only in trace amounts in the WT. This applies to oligomeric forms of CCB1 in the 70--110 kD region ([Fig. 4](#fig4){ref-type="fig"}, dashed boxes) and to oligomeric forms of CCB2/4/3 around 170 kD ([Fig. 4](#fig4){ref-type="fig"}, solid boxes). These observations suggest that these protein complexes are transiently formed in the process of heme delivery to cyt *b*~6~ in the WT but accumulate more extensively in the *petB-C35V* mutant because the last step of heme binding is impaired. The CCB1-containing oligomer at 70--110 kD remained visible in *ccb2*, *ccb4*, and *ccb3* mutants but was lost in the *ΔpetB* strain that lacks cyt *b*~6~ (apocytochrome *b*~6~ 24 kD), where CCB1 migrated only as a monomer of ∼45 kD of apparent molecular mass. Interestingly, an oligomeric form of cyt *b*~6~, which was visible in the same 70--110-kD region in the WT and in *petB-C35V*, *ccb2*, *ccb4*, and *ccb3* mutants, was depleted in the *ccb1* mutant. These migration patterns support the existence of a CCB1/*b*~6~ oligomer. Oligomeric forms of CCB2, CCB3, and CCB4 at 170 kD disappear altogether in the *ccb2*, *ccb3*, and *ccb4* mutants. This behavior is consistent with their association in a 170-kD complex. This 170-kD oligomer is also absent in the *ΔpetB* mutant, an observation that is consistent with an interaction between the CCB2/CCB4/CCB3 oligomer and cyt *b*~6~. We note that this complex is also absent in the *ccb1* mutant, although we found no evidence for the presence of CCB1 in the 170-kD region. Because formation of the CCB1/*b*~6~ oligomer still occurs in the *ccb2*, *ccb3*, and *ccb4* mutants, we suggest that formation of the CCB1/*b*~6~ oligomer is a prerequisite for the formation of the CCB2/CCB4/CCB3 oligomer in the process of *c*~i~-heme binding to cyt *b*~6~.

Interactions between the CCBs and cyt *b*~6~, as analyzed by coimmunoprecipitation
----------------------------------------------------------------------------------

To gather independent evidence for the association of several CCB factors in these oligomeric complexes, some of which likely contain cyt *b*~6~, we undertook complementary coimmunoprecipitation assays using antibodies raised against CCB3 peptides (α-CCB3), the N-terminal domain of subunit IV (α-IV), and the N-terminal (α-*b*~6~N) and C-terminal domains (α-*b*~6~C) of cyt *b*~6~ ([Fig. 5](#fig5){ref-type="fig"}). These antibodies detect the proteins against which they were prepared and not the other *b*~6~ *f* subunits or CCBs (controls not depicted). We used digitonin-solubilized membranes (as prepared for BN-PAGE) from the *petB-C35V* strain, as it shows the most abundant CCB oligomeric complexes in BN-PAGE. Coimmunoprecipitations were then assayed with polyclonal antibodies against peptides from cyt *f*, cyt *b*~6~, subunit IV, CCB1, CCB2, CCB3, and CCB4.

![**Coimmunoprecipitation analysis of CCBs and cyt *b*~6~ interactions.** Digitonin-solubilized membranes (prepared as for BN-PAGE) from the *petB-C35V* strain were incubated with protein A--Sepharose beads coupled to antibodies against peptides of CCB3 (α-CCB3), subunit IV N terminus (α-IV), cyt *b*~6~ C terminus (α-*b*~6~C), and cyt *b*~6~ N terminus (α-*b*~6~N), or against respective preimmune serum (pi). (a) Coimmunoprecipitations with α-CCB3 and α-IV. (b) Coimmunoprecipitations with α-*b*~6~C and α-*b*~6~N. Aliquots of digitonin-solubilized membranes (sol) and immunoprecipitates (IP) were separated by SDS-PAGE and analyzed by immunoblotting. (c) Top view from the *n* side of the membrane and (d) side view in the membrane plane of the cyt *b*~6~ structure. Images in c and d were generated using PyMol and the coordinates from pdb file 1Q90 with α-*b*~6~N peptide antigen in red, α-*b*~6~C peptide antigen in green, *b*~L~ and *b*~H~-hemes in brown, *c*~i~-heme in orange, and Cys35 in yellow.](JCB_200812025_RGB_Fig5){#fig5}

[Fig. 5 a](#fig5){ref-type="fig"} shows that α-CCB3 coimmunoprecipitates CCB2, CCB4, and cyt *b*~6~ but not CCB1, subunit IV, and cyt *f*. These results confirm that CCB3 indeed interacts with CCB2, CCB4, and cyt *b*~6~, as suggested by the existence of the 170-kD oligomeric form of these three CCB components in BN-PAGE. That α-CCB3 pulls down cyt *b*~6~ but not the other *b*~6~ *f* subunits and that α-IV pulls down *b*~6~ *f* subunits but no CCB components ([Fig. 5 a](#fig5){ref-type="fig"}) indicates that CCBs interact with cyt *b*~6~ before its assembly within the *b*~6~ *f* complex.

Coimmunoprecipitations with α-*b*~6~C and α-*b*~6~N pulled down subunit IV and cyt *f* as expected from the formation of *b*~6~ *f* complexes in the *petB-C35V* mutant (see the following results section). In addition, α-*b*~6~C coimmunoprecipitated the four CCBs, whereas α-*b*~6~N coimmunoprecipitated only CCB3 out of the four CCBs ([Fig. 5 b](#fig5){ref-type="fig"}). These results support the interaction of the CCB2/CCB4/CCB3 oligomer with cyt *b*~6~, as suggested by our BN-PAGE study. They also confirm the formation of CCB1/*b*~6~ and CCB3/*b*~6~ complexes. When using WT membranes, α-*b*~6~N and α-*b*~6~C coimmunoprecipitated subunit IV and cyt *f* but little if any CCBs (unpublished data), which is consistent with the low amount of CCB hetero-oligomers interacting with cyt *b*~6~, as detected in BN-PAGE experiments in the WT.

The difference between α-*b*~6~C, which coimmunoprecipitates the four CCBs, and α-*b*~6~N, which selectively coimmunoprecipitates CCB3, suggests that the binding site of α-*b*~6~N on cyt *b*~6~ is masked whenever this cyt interacts with CCB1 or CCB2/CCB4/CCB3, thereby preventing α-*b*~6~N access to its epitope. This steric constraint is consistent with the folding of polypeptide chains around the Q~i~ site in the vicinity of the *c*~i~-heme--binding site, as revealed by the three-dimensional structure of *b*~6~ *f* complexes. Indeed, a heme ligation complex is expected to interact with cyt *b*~6~ on the stromal end of its first transmembrane helix in order to covalently attach *c*~i~-heme by a thioether bond to Cys35 ([Fig. 5, c and d](#fig5){ref-type="fig"}). In the *b*~6~ *f* complex structure ([@bib42]), the N terminus of cyt *b*~6~ forms an amphipathic helix lying parallel to the membrane plane on the stromal face of the membrane near the quinone binding site Q~i~. The Q~i~ site opens onto the hydrophobic groove at the dimer interface.

α-*b*~6~C coimmunoprecipitation before BN-PAGE depleted the digitonin extract in most of the CCB2/CCB4/CCB3-containing complex at 170 kD as well as in the CCB1-containing complexes found in the 70--110-kD region. In contrast, it did not modify the level of CCB2/CCB4-containing oligomers of 70 kD. These results confirm that cyt *b*~6~ is associated with the two oligomeric complexes of higher molecular mass but not with the CCB2/CCB4 heterodimer ([Fig. 6](#fig6){ref-type="fig"}).

![**CCB complex depletion by α-*b*~6~C coimmunoprecipitation in BN-PAGE.** Half of the digitonin-solubilized membranes from the *petB-C35V* strain were incubated with protein A--Sepharose beads coupled to antibodies against a peptide of cyt *b*~6~ C terminus (α-*b*~6~C). Digitonin-solubilized proteins without immunoprecipitation (−IP) and of the unbound fraction after α-*b*~6~C immunoprecipitation (+IP) were separated in the first dimension by the same BN-PAGE and in the second dimension by SDS-PAGE, and analyzed by ECL immunodetection. CCB2/CCB4/CCB3/*b*~6~ (solid boxes), CCB1/*b*~6~ (dashed boxes), and CCB2/CCB4 heterodimer (circles) are indicated.](JCB_200812025_GS_Fig6){#fig6}

To identify heme-containing intermediates among the CCBs, we attempted to detect peroxidase activity caused by covalent heme binding on these proteins after SDS-PAGE. We used the whole membrane fraction as well as digitonin-solubilized membranes followed by α-*b*~6~C coimmunoprecipitation from the *petB-C35V* strain, which accumulates assembly intermediates. We failed to detect any sign of peroxidase activity in either case. It is of note that we were able to detect peroxidase activity of 1% but not of 0.1% of cyt *f* using serial dilutions of SDS-solubilized WT membranes ([Fig. S1](http://www.jcb.org/cgi/content/full/jcb.200812025/DC1)). Thus, assuming that the mRNA ratios would reflect protein ratios for nucleus-encoded products (i.e., 70-fold less mRNA accumulation for *CCB* genes than for nuclear genes encoding *b*~6~ *f* complex subunits; Karpowicz, S., and S. Merchant, personal communication) and that assembly intermediates recruit most of the CCBs, we would tentatively conclude the absence of covalent heme binding to any of the CCBs.

*b*~6~*f* complex assembles in the absence of *c*~i~-heme binding but is highly protease sensitive
--------------------------------------------------------------------------------------------------

By BN-PAGE, we could also investigate the state of *b*~6~ *f* complex assembly ([Fig. 7 a](#fig7){ref-type="fig"}). In the WT, dimers and monomers of *b*~6~ *f* complex were easily detected by comigration of cyt *f*, cyt *b*~6~, and subunit IV at 320 kD and 140 kD, respectively ([Fig. 7 a](#fig7){ref-type="fig"}), which is in agreement with previous studies ([@bib4]; [@bib24]). Despite the low abundance of *b*~6~ *f* subunits in the *petB*-*C35V* strain, as well as in all *ccb* mutant strains (see cyt *b*~6~ in [Fig. 4](#fig4){ref-type="fig"}, other *b*~6~ *f* subunits not shown), dimeric and monomeric forms of *b*~6~ *f* complex could still be detected, which indicates that covalent binding of the *c*~i~-heme is not a prerequisite for assembly of cyt *b*~6~ within *b*~6~ *f* complexes. However, the low accumulation of the *b*~6~ *f* complex in *petB*-*C35V* and *ccb* mutant strains ([@bib21]; [@bib7]) suggests that *c*~i~-heme binding contributes to the folding of *b*~6~ *f* complexes in a protease-resistant form. This lower accumulation is not visible in [Fig. 4](#fig4){ref-type="fig"} and [Fig. 7 a](#fig7){ref-type="fig"} because we overexposed the immunoblots for the *b*~6~ *f* subunits in the *ccb* and *petB-C35V* mutants, as compared with that in the WT (exposure time of 2 min instead of 20 s). In contrast, the assembly of *b*~6~ *f* complex was totally impaired in substitution mutants lacking either one of the four conserved histidines in the sequence of cyt *b*~6~, which are axial ligands of *b*~H~- or *b*~L~-hemes ([Fig. 7 a](#fig7){ref-type="fig"}).

![**Analysis of *b*~6~*f* complex assembly in BN-PAGE and activity in vivo.** (a) *b*~6~*f* complexes after BN-PAGE of digitonin-solubilized membranes. Shown are a WT strain, *petB-C35V* (-*c*~i~) strain, and *petB-H202Q* (-*b*~H~) strain: a site-directed mutant of the chloroplast *petB* gene with a substitution of His202 involved as an axial ligand of *b*~H~-heme preventing *b*~H~-heme binding to cyt *b*~6~. *petB-H187G* (-*b*~L~) strain: site-directed mutant of the chloroplast *petB* with a substitution of His187 involved as axial ligand of *b*~L~-heme preventing *b*~L~-heme binding to cyt *b*~6~. Digitonin-solubilized proteins were separated in the first dimension by BN-PAGE and in the second dimension by SDS-PAGE and analyzed by ECL immunodetection. *b*~6~*f* complex migrates as a dimer of 320 kD (*b*~6~*f*~dimer~) and as a monomer of 140 kD (*b*~6~*f*~monomer~), both highlighted by arrows. (b) Fluorescence induction kinetics of dark-adapted cells from *WT*, *petB-C35V*, and *ΔpetB* strains.](JCB_200812025_RGB_Fig7){#fig7}

We wondered whether these assembled forms of *b*~6~ *f* complex retained any functional properties. To this end, we closely examined the fluorescence induction patterns in vivo of *ccb* and *petB-C35V* mutants. In vivo fluorescence induction kinetics were measured using low actinic light followed by a saturating pulse to determine F~max~. As shown in [Fig. 7 b](#fig7){ref-type="fig"}, the stationary fluorescence in the *petB-C35V* strain was higher than in the WT but remained well below F~max~ in these experimental conditions. Similar fluorescence data were obtained with the four *ccb* strains (not depicted). In contrast, both the *ΔpetB* strain ([Fig. 7 b](#fig7){ref-type="fig"}) and the substitution mutants of the axial ligands of *b*~H~- and *b*~L~-hemes (not depicted) showed a stationary fluorescence very close to F~max~, as expected from the block in electron transfer between PSII and PSI. These results indicate that the plastoquinone pool is not fully reduced in the stationary state in *petB-C35V* and *ccb* strains under our light intensity conditions. Thus, the low amount of assembled *b*~6~ *f* complex lacking covalent binding of the *c*~i~-heme contributes to some reoxidation of the plastoquinol pool at low light intensity.

Discussion
==========

Polytopic transmembrane topologies of CCB1--4
---------------------------------------------

The CCBs are required for covalent attachment of *c*~i~-heme to cyt *b*~6~ in the thylakoid membrane. These proteins are encoded by the nuclear genome, translated as precursors with N-terminal transit peptides to the chloroplast, where they are inserted within membranes ([@bib22]; [@bib26]). Based on the analysis of the CCB sequences, we previously proposed that CCB1--4 proteins had a similar topology in *C. reinhardtii* ([@bib22]) and in *A. thaliana* ([@bib26]). Our protein folding model ([@bib22]) took into account the prediction of TMDs using multiple sequence alignments (TMAP; [@bib33]) and the prediction of the localization of positively charged segments by the "positive inside rule" at the borders of the putative TMDs ([@bib12]). This transmembrane organization is supported here by our biochemical study, based on chaotropic extraction, protease accessibility, and split ubiquitin data ([Fig. 1 c](#fig1){ref-type="fig"}). In particular, the high protease sensitivity in the absence of vesicle sonication of the two homologues CCB2 and CCB4 is easily explained by their large C-terminal domains exposed to the stromal side of the membranes. Split ubiquitin experiments are consistent with a localization of N and C termini of CCB2 and CCB4 in the yeast cytosol (the compartment corresponding to the chloroplast stroma), thereby confirming our folding model with two TMDs. CCB1 is degraded at a higher trypsin concentration than CCB2 and CCB4, as expected for a protein with three TMDs and short stromal exposed domains. Split ubiquitin experiments further support the localization of the C terminus of CCB1 in the cytosol. CCB3 is very resistant to trypsin treatments, as expected for a hydrophobic protein with two TMDs and short N and C termini exposed to the lumen. That we did not detect a CCB3 digestion product corresponding to the mature protein missing the three C-terminal amino acid residues further supports the lumenal localization of the C terminus of CCB3.

CCB2 and CCB4 form a stable heterodimer
---------------------------------------

This study provides extensive evidence for the association of CCB2 and CCB4 in a stable heterodimer in vivo. They accumulate in a concerted manner in *C. reinhardtii* and they interact in two hybrid experiments. Moreover BN-PAGE showed that they are part of a 70-kD complex in all *C. reinhardtii* strains we examined, except for *ccb2* and *ccb4* mutants, which lack these two proteins. CCB2 and CCB4 are derived from a unique cyanobacterial ancestor likely duplicated upon endosymbiosis ([@bib22]). It is likely that cyanobacteria contain a CCB2/4-like homodimer. The molecular information born by a single CCB2/4-like protein in cyanobacteria is split between the eukaryotic CCB2 (about 30 residues after the second TMD) and CCB4 (mainly in the protein C terminus) with little redundancy ([Fig. S2](http://www.jcb.org/cgi/content/full/jcb.200812025/DC1)), which further substantiates the need for heterodimer formation in the latter case. The photosynthesis apparatus offers two other remarkable examples of heterodimer formation between two homologous proteins: the two core proteins of PSII (D1 and D2) and the two core subunits of PSI (PsaA and PsaB). In the case of type I reaction centers, a homodimer of pshA, still found in some bacteria like heliobacteria, is reminiscent of the ancestral PSI (for review see [@bib17]).

Distinct CCB hetero-oligomers interact with cyt *b*~6~
------------------------------------------------------

The presence or absence of cyt *b*~6~ had no influence on the accumulation level of any of the CCBs. However, based on BN-PAGE and coimmunoprecipitation experiments, we could identify several hetero-oligomers that interact with cyt *b*~6~: a CCB1/*b*~6~ complex of ∼70-110 kD and a CCB2/CCB4/CCB3 protein complex of 170 kD in BN-PAGE, the existence of which are confirmed by their coimmunoprecipitation with cyt *b*~6~. The accumulation of these protein complexes is particularly visible in the *petB-C35V* strain. Therefore, we consider that these CCB/*b*~6~ hetero-oligomers are transiently formed in the process of heme delivery to the cyt *b*~6~ substrate and are trapped in the *petB-C35V* mutant, which contains the same CCB protein complement as in the WT but is blocked at the very last step of *c*~i~-heme binding to cyt *b*~6~. We noted that α-*b*~6~C coimmunoprecipitates the four CCBs, whereas α-*b*~6~N selectively coimmunoprecipitates CCB3. Collectively, these observations argue for the formation of an additional CCB3/*b*~6~ complex, distinct from CCB1/*b*~6~ and CCB2/CCB4/CCB3/*b*~6~ complexes, a conclusion further supported in BN-PAGE by the shift to a lower apparent molecular mass of the CCB3-containing band in the *ΔpetB* strain. The *b*~6~ *f* monomer and dimer were estimated to contain ∼60% protein and prosthetic groups and 40% detergents and lipids ([@bib4]). Assuming (1) the same protein to lipid/detergent ratio in each CCB-containing oligomer and (2) that they would contain only one copy of their constitutive subunits, the 170-kD CCB2/CCB4/CCB3/*b*~6~ oligomer would have a calculated mass of 155 kD (protein mass of 93 kD), and the 70--110-kD CCB1/*b*~6~ oligomer would have a calculated mass of 82 kD (protein mass of 49 kD). Although these calculated values compare well with those from BN-PAGE, we cannot exclude that these three hetero-oligomers would contain additional protein subunits, as yet unknown CCB factors, or several copies of some of their subunits.

Tentative model for a CCB-mediated apo- to holo-cyt *b*~6~ conversion
---------------------------------------------------------------------

Transient and stable complexes are required for cyt *c* biogenesis on the *p* side of membranes. In bacterial/mitochondrial system I, cyt *c* maturation E (CcmE) binds heme covalently ([@bib41]) upon interaction with CcmC and CcmD ([@bib37]; [@bib1]). Holo-CcmE is then released by the CcmA/CcmB ABC transporter ([@bib5]; [@bib36]). CcmE then interacts with CcmF and CcmH to perform heme ligation to the apocytochrome ([@bib37]; [@bib29]; [@bib35]; [@bib38]). In bacterial--cyanobacterial--chloroplast system II, CCSA and CCS1 are part of a 200-kD heme delivery complex ([@bib10]; [@bib16]). In mitochondrial system III, cyt *c* and *c*~1~-heme lyases have been identified, and interactions between heme lyase and apocytochrome *c* have been demonstrated ([@bib28]).

We expect that system IV, composed of CCBs, should have features distinct from the three other systems because it develops on the opposite side of the membranes. Furthermore, the ferrochelatase produces the heme and the *c*~i~-heme--binding site, with both on the stromal side of the membrane, and we do not expect the need for a transmembrane protein that would translocate the heme from one side of the membrane to the other, as it must occur for cyt biogenesis systems on the *p* side of the membranes. For example, the CCSA--CCS1 complex is believed to perform this initial step before heme binding on the apocytochrome. Indeed, the experimentally tested transmembrane topologies of CCB1--4 protein confirm that most of the conserved tryptophane and/or tyrosine residues that are expected to interact with heme from what is currently known in other maturation systems are all located on the *n* side of the thylakoid membranes. These conserved residues might participate in heme chaperoning and delivery to cyt *b*~6~ on the stromal side of the membranes. We also note that none of the four CCB factors has conserved cysteine residues, which are critical for apocytochrome and/or heme reduction in system I--II, as exemplified by the membrane-anchored thioredoxin-like protein HCF164 ([@bib25]; [@bib30]) that would interact with the transmembrane protein CCDA ([@bib31]) as a redox relay component required for reduction of the two cysteines at the heme-binding site of apocytochromes *f* and *c*~6~. We cannot exclude that it is merely due to the existence of additional protein factors that have escaped our genetic screen. However, one should consider the possible absence of catalytic cysteines in the process of heme binding on the *n* side of membranes because of numerous chemical species that have the potential to maintain the protein thiols in the stroma and cyanobacterial cytoplasm, such as the presence of thioredoxins that maintain largely reduced cysteine residues (for review see [@bib18]). We cannot exclude either an unusual heme-binding process by a unique thioether bond or the easier access of heme-delivery complexes to the ferrous heme produced by the neighboring ferrochelatase ([@bib44]). However, none of the four CCBs displays a conserved histidine residue, which is involved in covalent heme binding to CcmE in system I ([@bib41]). Collectively with our inability to detect any peroxidase activity associated with the CCBs, this argues for the absence of a CCB intermediate carrying a covalently bound heme.

The various CCB-containing complexes that we identified in *C. reinhardtii* have given us access to some supramolecular traits of the biogenesis pathway for cyt *b*~6~ on the *n* side of membranes. First, covalent binding of the *c*~i~-heme to cyt *b*~6~ occurs independently of its assembly within the *b*~6~ *f* complex. This is demonstrated by the diffuse aspect of the electrophoretic band for cyt *b*~6~ in deletion mutants lacking other *b*~6~ *f* subunits, which is diagnostic of *c*~i~-heme binding, instead of a double band in the absence of heme binding ([@bib21]). This is further supported by direct evidence for an interaction of cyt *b*~6~ with CCB components, with the observation of a 70--110-kD CCB1/*b*~6~ complex in BN-PAGE at much lower apparent molecular masses than assembled forms of *b*~6~ *f* complexes. The fact that interactions between cyt *b*~6~ and the CCBs occur before its assembly within *b*~6~ *f* complexes is demonstrated by our coimmunoprecipitation experiments in which α-CCB3 pulls down only cyt *b*~6~ among *b*~6~ *f* subunits, whereas α-IV did not pull down any CCB. That unassembled cyt *b*~6~ but not the subunit IV--cyt *b*~6~ complex is the substrate for the CCB machinery is consistent with the view that a split cyt *b* would be a prerequisite for *c*~i~-heme insertion ([@bib42]).

The full maturation of cyt *b*~6~ through the CCB-heme--delivering pathway is not required for its assembly within *b*~6~ *f* complexes, as we detected both monomeric and dimeric forms of the protein complex in the absence of *c*~i~-heme binding. A similar observation was recently reported for a *ccb2* mutant in *A. thaliana*. This mutant had a high chlorophyll fluorescence phenotype and showed no evidence for photosynthetic electron transport ([@bib27]). This is in contrast to our observation that the *c*~i~-heme--binding defective strains in *C. reinhardtii* retain some activity in plastoquinol oxidation, as suggested by their fluorescence properties when illuminated at low light intensity. However, this activity in plastoquinol oxidation did not allow phototrophic growth in standard conditions (growth medium lacking reduced carbon sources, light intensities of 40--100 μE/m^2^/s, ambient air and room temperature), which allowed us to recover the *CCB* genes by complementation with a selection scheme based on the restoration of phototrophy ([@bib22]).

That *b*~6~ *f* complexes can assemble in the absence of *c*~i~-heme binding is in marked contrast to the required coordination of hemes *b*~H~ and *b*~L~ for cyt *b*~6~ assembly within *b*~6~ *f* complexes, as shown by our comparative BN-PAGE experiments. As we observed *b*~6~ *f* complex assembly in each *ccb* mutant, we can exclude that either of these CCBs is required for the formation of an assembly competent form of a *b*-heme--containing cyt *b*~6~.

On the basis of heme depletion upon gabaculine treatment and after analysis of mutants lacking axial ligands of *b*~L~-heme or *b*~H~-heme, we previously proposed that formation of a *b*~L~-heme--dependent intermediate can be prevented by gabaculine treatment ([@bib21]). Our sequential model for *b*~L~ integration as a prerequisite for *b*~H~ integration within apocytochrome *b*~6~ has recently been supported by heterologous expression studies of mutant variants of cyt *b*~6~ in *Escherichia coli* ([@bib9]). The biochemical data gathered in the present study allowed us to further enrich our original model for cyt *b*~6~ maturation ([@bib21]), with sequential binding of *b*~L~-heme, *b*~H~-heme, and *c*~i~-heme before assembly with other *b*~6~ *f* subunits ([Fig. 8](#fig8){ref-type="fig"}). In *ccb* and *petB-C35V* mutants, assembly of the *b*~6~ *f* complex continues despite the absence of covalent binding of *c*~i~-heme. The resulting complex shows limited accumulation in the thylakoid membranes, probably because it displays an increased protease sensitivity.

![**Tentative model for a CCB-mediated apo- to holo-cyt *b*~6~ conversion.** Model with the following steps: membrane integration of apocyt *b*~6~, formation of a *b*~L~-heme--dependent intermediate that can be prevented by heme depletion (gabaculine treatment), and formation of a *b*~L~ and *b*~H~ binding cyt *b*~6~ ([@bib21]); formation of a transient oligomer comprising CCB1/*b*~6~, formation of a transient oligomer comprising CCB3/*b*~6~, association of the oligomer comprising CCB3/*b*~6~ with the stable heterodimer CCB2/CCB4 to form the heme ligation complex, and a transient oligomer comprising CCB2/4/3/*b*~6~, which is stabilized in *petB-C35V* strain; *c*~i~ binding leads to a holocyt *b*~6~ with three hemes; and cyt *b*~6~ associates with other *b*~6~*f* subunits even in the absence of *c*~i~-heme covalent binding. The binding site of α-*b*~6~N on cyt *b*~6~ (N) is masked whenever this cyt interacts with CCB1 or CCB2/CCB4/CCB3, thereby preventing α-*b*~6~N access to its epitope. The question mark indicates that CCB3/*b*~6~ is a transient protein complex that may arise before formation or after dissociation of the CCB2/CCB4/CCB3/*b*~6~ complex.](JCB_200812025_RGB_Fig8){#fig8}

In our model for a CCB-mediated apo- to holo-cyt *b*~6~ conversion ([Fig. 8](#fig8){ref-type="fig"}), formation of a transient CCB1/*b*~6~ oligomer that suggests a role of CCB1 in cyt *b*~6~ chaperoning is followed by formation of a transient CCB3/*b*~6~ oligomer. The latter then recruits the stable CCB2/CCB4 heterodimer to form the membrane-integral multisubunit heme ligation complex comprised of CCB2, CCB4, and CCB3, interacting with the cyt *b*~6~. Whether CCB3/*b*~6~ is an intermediate before formation (as shown in [Fig. 8](#fig8){ref-type="fig"}) or after dissociation of CCB2/CCB4/CCB3/*b*~6~ complex is still an open question; indeed, CCB3 is mainly monomeric in the *ΔpetB* mutant but surprisingly still oligomerizes in *ccb1*, *ccb2*, and *ccb4* mutants. Concerning the specific roles of CCB2 and CCB4, one could speculate that CCB2, the less conserved CCB protein, would have evolved to adapt for heme scavenging in different organisms performing oxygenic photosynthesis, whereas the better conserved CCB4 protein would pack closely with CCB3 and cyt *b*~6~, whose sequences are also well conserved. The binding of *b*-hemes to apocytochrome *b*~6~ before *c*~i~-heme binding makes it difficult to assess unambiguously the possible association of a heme with the CCB moiety of these transient oligomers. Once *c*~i~-heme is thioether bound to Cys35 of cyt *b*~6~, this membrane-integral multisubunit heme ligation complex dissociates, freeing CCB3 and the stable CCB2/CCB4 heterodimer, now available for a new round of catalysis.

The photosynthetic apparatus requires a diversity of biogenesis pathways for cofactor delivery to their protein substrates. With the present biochemical dissection of the CCB pathway, we now have a refined view of the protein scaffold involved in heme delivery to the photosynthetic membranes. In that respect, it is of note that the two machineries for heme delivery on the stromal and lumenal side of the membranes appear not to share any common protein components: mutants defective for the CCS pathway (heme binding on the lumenal side) showed unaltered heme binding to cyt *b*~6~, and, similarly, CCB mutants show unaltered heme binding to cyt *f* ([@bib22]). How neosynthesized heme is distributed between these two pathways remains to be explored.

Materials and methods
=====================

Strains and culture conditions
------------------------------

*C. reinhardtii* mutants have been described previously and were as follows: *ccb*, *petB-C35V*, *petB-H202Q*, *petB-H137G*, and *ΔpetB* ([@bib21], [@bib22]; [@bib7]). Cells were grown at 25°C in Tris acetate phosphate (TAP) medium, pH 7.2, under dim light (6 μE/m^2^/s) and collected during the exponential phase at 2 × 10^6^ cells per milliliter.

Protein preparation and analysis
--------------------------------

Cell preparation and chaotropic extractions of membrane proteins were performed as described previously ([@bib3]; [@bib7]), except that supernatants from NaCl and NaI extractions were washed on microcon (YM-3; Millipore) in DTT-Na~2~CO~3~ 0.1 M. For proteolysis experiments, French press--derived thylakoid membrane vesicles were prepared extemporaneously as in [@bib6] but without protease inhibitors, and finally washed twice with 20 mM Tris-HCl, pH 8.0. Various concentrations of trypsin were added to thylakoid membranes at a final chlorophyll concentration of 270 μg/ml. Half of each sample was sonicated three times for 10 s on ice. Trypsin treatments were performed at room temperature for 30 min, and the reaction was arrested by adding 2 mM phenyl methylsulfonylfluoride as an inhibitor. Polypeptides were separated on 12--18% SDS-polyacrylamide gels in the presence of 8 M urea ([@bib8]). Proteins were electrotransferred onto Immobilon NC membranes (Westran S membranes; GE Healthcare) in a semidry blotting apparatus at 0.8 mA/cm^2^ for 45 min. For immunodetection by the chemoluminescence method (GE Healthcare), we used antisera against cyt *b*~6~, cyt *f*, subunit IV, PSII OEE subunits, and ATP synthase β subunit at a 1:10,000 dilution; CCB3 at a 1:2,500 dilution; and CCB1, CCB2, and CCB4 at a 1:300 dilution.

Yeast split ubiquitin two-hybrid assays
---------------------------------------

The principle is based on the in vivo split ubiquitin reconstitution caused by the strong interaction of the two ubiquitin moieties. The WT N-terminal half of ubiquitin (NubI) interacts with the C-terminal half of ubiquitin (Cub) even if these domains are fused to transmembrane proteins that do not interact; it is used as a positive control of transmembrane protein expression. Because the mutated N-terminal half of ubiquitin with a substituted isoleucine at position three for a glycine (NubG) has a lower affinity than NubI for Cub, it allows split ubiquitin reconstitution only when the two domains are fused to transmembrane proteins that interact. The transcription factor LexA-VP16 is fused to the Cub domain. Upon interaction of Cub and NubG or NubI, the polypeptide chain between Cub and LexA-VP16 is cleaved. It can translocate to the nucleus and activate transcription of genes, allowing growth in the absence of adenine or histidine or allowing β-galactosidase activity. The cleavage and translocation of the transcription factor require the two ubiquitin moieties located in the yeast cytoplasm. We used Alg5, a yeast transmembrane protein that is not expected to interact with our proteins of interest, fused to NubI as an expression control, or fused to NubG or Cub as an interaction test control. cDNA fragments coding for mature CCB1, CCB2, CCB4, and cyt *b*~6~ were amplified by polymerase chain reaction (TripleMaster; Eppendorf) using primers listed in [Table S1](http://www.jcb.org/cgi/content/full/jcb.200812025/DC1) that all contained a SfiI site used to fuse in frame the coding sequences to the ubiquitin NubG domain (pPR3-STE vector) and the ubiquitin Cub domain (pBT3-STE vector; DUALmembrane kit3; Dualsystems Biotech). The yeast NYM51 strain (Mata, leu2, trp1, his3, ade2, LYS2::(lexAop)~4~-HIS3, ade2::(lexAop)~8~-ADE2, ura3::(lexAop)~8~-lacZ) was cotransformed with combinations of constructs expressing proteins fused to NubG and Cub domains. Cotransformants were allowed to grow for 3 d at 30°C on synthetic medium (SD) lacking leucine and tryptophan. The interaction between two proteins at the yeast membrane results in the activation of reporter genes *ADE2*, *HIS3*, and *lacZ*. The expression of auxotrophic growth markers *ADE2* and *HIS3* was monitored by the growth on a medium lacking adenine and histidine in the presence of 10 mM 3-aminotriazole. The expression of *lacZ* was followed by measuring at OD~417nm~ the accumulation of the product metabolized by β-galactosidase with 2.2 mM o-NPG (2-nitrophenyl β-D-galactopyranoside; Sigma-Aldrich) as a substrate ([@bib35]). A construct expressing Cub fused to the protein of the yeast endoplasmic reticulum Alg5 (pCCW-Alg5 vector) was used as negative control for the NubG fusions. In the same way, a construct expressing NubG fused to Alg5 (pDL2-Alg5 vector) was used as negative control for Cub fusions. Transformations in yeast were controlled by growth on a medium lacking both leucine and tryptophan.

BN-PAGE and immunoprecipitations
--------------------------------

Membrane fractions were prepared from sonicated cell lysates as in [@bib22]. All steps up to the second dimension analysis were performed at 4°C. Membrane fraction was pelleted in a TLA-100.3 rotor (Beckmann Coulter) at 270,000 *g* for 10 min and resuspended in 50 mM Bis-Tris, pH 7.0, supplemented with 1× complete EDTA-free protease inhibitor mixture (Roche). Immediately after preparation, membranes were solubilized for 30 min in 50 mM Bis-Tris, pH 7.0, and 416 mM aminocaproic acid by 2.5% freshly prepared digitonin at a final concentration of chlorophyll of 0.75 mg/ml (corresponding to 6.68 g of detergent per gram of protein). Taurocholic acid (Sigma-Aldrich) was added to supernatant recovered after centrifugation in a TLA-100 rotor (Beckmann Coulter) at 250,000 *g* for 30 min, to a final concentration of 0.25% (wt/vol). Supernatant and molecular weight markers (gel filtration calibration kit HMW; GE Healthcare) in 50 mM Bis-Tris, pH 7.0, and 416 mM aminocaproic acid were loaded on a BN polyacrylamide gel ([@bib39]) with a 3% acrylamide stacking gel and a 6--18% acrylamide separating gel. Electrophoresis was initiated with cathode buffer containing 0.02% Coomassie blue for 1 h at 150 V, then overnight at 380 V. The buffer was then exchanged with new cathode buffer containing 0.002% Coomassie blue, and electrophoresis was continued for 6 h at 600 V. For the denaturizing second dimension analysis, strips cut out from the first BN gel were incubated at room temperature twice for 15 min in 1% SDS, 1 mM EDTA, 10 mM DTT, 100 mM Na~2~CO~3~, and protease inhibitors (200 μM phenylmethylsulfonyl fluoride, 1 mM benzamidine, and 5 mM aminocaproic acid), then washed five times for 5 min in 0.25 M Tris, 1.92 M glycine, 0.01% SDS, and 1 mM EDTA. The strips of BN-PAGE were then embedded in a stacking gel on top of a resolving 12--18% SDS-polyacrylamide gel containing 8 M urea, then electrotransferred and analyzed by immunoblotting. For immunoprecipitations, antibodies were coupled to protein A--Sepharose beads as in [@bib40]. The coupled beads were washed twice in 50 mM Bis-Tris, pH 7.0, 416 mM aminocaproic acid, and 0.2% digitonin, and incubated with digitonin-solubilized membranes (prepared as for BN-PAGE) for 1 h at 4°C. After immunoprecipitation, the coupled beads were washed three times in the previous solution and then twice in 10 mM Tris-HCl, pH 7.5. Immunoprecipitated proteins were recovered by resuspending the beads in 2% SDS and 12% sucrose and boiling for 50 s. After centrifugation, the supernatant was complemented to 0.1 M DTT and 0.1 M Na~2~C0~3~, and analyzed by SDS-PAGE. Peptide sequences recognized for immunoprecipitation and/or immunodetection experiments were SVTKKPDLSPDVLKY for α-IV ([@bib34]), SKVYDWFEERLEIQ for α-*b*~6~N, and LMIRKQGISGPL for α-*b*~6~C ([@bib7]), which are localized in cyt *b*~6~ structure in [Fig. 5 (c and d)](#fig5){ref-type="fig"}; and RYYFKRYNYDVKETGE for α-CCB1, FSERPRALADRERGW for α-CCB2, GSCLAADSPENAEQTV and GPQGLLTLIQQRGGL for α-CCB3, and TVDFVEPGLKPYA for α-CCB4 ([@bib22]), which are localized in CCBs transmembrane topology in [Fig. 1 c](#fig1){ref-type="fig"}.

Biophysical measurements
------------------------

Fluorescence kinetics were measured with a JTS10 spectrometer (Bio-Logic). Cells were dark-adapted for 1 min before each experiment. A low intensity (150 μE/m^2^/s) continuous illumination was provided with an orange electroluminescent diode (620 nm), a light condition which generates a photosynthetic linear electron transfer of 100 electrons per second in the WT. A saturating pulse was added in the end of the low-light period to fully reduce the quinone pool. Fluorescence was detected with high-pass colored RG695 filters (Schott).

Online supplemental material
----------------------------

Fig. S1 shows the absence of detectable covalent heme binding on CCBs. Fig. S2 shows sequence alignments of CCB2 and CCB4 orthologues with conserved domains repartition highlighted, and schematizes their transmembrane topology. Table S1 describes primers, templates, and vectors used for split-ubiquitin experiments. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200812025/DC1>.
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